These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16777680)

  • 21. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
    Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
    Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
    Gao J; Zhong W; He J; Li H; Zhang H; Zhou G; Li B; Lu Y; Zou H; Kou G; Zhang D; Wang H; Guo Y; Zhong Y
    Int J Pharm; 2009 Jun; 374(1-2):145-52. PubMed ID: 19446771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.
    Brignole C; Marimpietri D; Gambini C; Allen TM; Ponzoni M; Pastorino F
    Cancer Lett; 2003 Jul; 197(1-2):199-204. PubMed ID: 12880982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery.
    Haeri A; Zalba S; Ten Hagen TL; Dadashzadeh S; Koning GA
    Colloids Surf B Biointerfaces; 2016 Oct; 146():657-69. PubMed ID: 27434152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model.
    Carolina Cruz de Sousa A; da Silva Santos E; da Silva Moreira T; Gabriela Araújo Mendes M; Rodrigues Arruda B; de Jesus Guimarães C; de Brito Vieira Neto J; Santiago de Oliveira Y; Pedro Ayala A; Rodrigues da Costa MD; Lima Sampaio T; Paula Negreiros Nunes Alves A; Pessoa C; Petrilli R; Eloy JO
    Int J Pharm; 2024 Aug; 661():124439. PubMed ID: 38972520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells.
    Limasale YD; Tezcaner A; Özen C; Keskin D; Banerjee S
    Int J Pharm; 2015 Feb; 479(2):364-73. PubMed ID: 25595386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
    Vega J; Ke S; Fan Z; Wallace S; Charsangavej C; Li C
    Pharm Res; 2003 May; 20(5):826-32. PubMed ID: 12751641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
    Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
    Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular association and cytotoxicity of doxorubicin-loaded immunoliposomes targeted via Fab' fragments of an anti-CD74 antibody.
    Lundberg BB; Griffiths G; Hansen HJ
    Drug Deliv; 2007 Mar; 14(3):171-5. PubMed ID: 17454037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization.
    Schmiedel J; Blaukat A; Li S; Knöchel T; Ferguson KM
    Cancer Cell; 2008 Apr; 13(4):365-73. PubMed ID: 18394559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
    Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.
    Cheng WW; Allen TM
    Expert Opin Drug Deliv; 2010 Apr; 7(4):461-78. PubMed ID: 20331354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic Effects of PEGylated Anti-EGFR Immunoliposomes Combined with Doxorubicin and Rhenium-188 Against Cancer Cells.
    Hsu WC; Cheng CN; Lee TW; Hwang JJ
    Anticancer Res; 2015 Sep; 35(9):4777-88. PubMed ID: 26254368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of anti-p185HER2 immunoliposomes for cancer therapy.
    Park JW; Hong K; Carter P; Asgari H; Guo LY; Keller GA; Wirth C; Shalaby R; Kotts C; Wood WI
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1327-31. PubMed ID: 7877976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes.
    Wang J; Wu Z; Pan G; Ni J; Xie F; Jiang B; Wei L; Gao J; Zhou W
    Nanomedicine; 2018 Aug; 14(6):1949-1961. PubMed ID: 29045824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sortagged anti-EGFR immunoliposomes exhibit increased cytotoxicity on target cells.
    Wöll S; Dickgiesser S; Rasche N; Schiller S; Scherließ R
    Eur J Pharm Biopharm; 2019 Mar; 136():203-212. PubMed ID: 30677497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.
    Cheng L; Huang FZ; Cheng LF; Zhu YQ; Hu Q; Li L; Wei L; Chen DW
    Int J Nanomedicine; 2014; 9():921-35. PubMed ID: 24611009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.